| A serological assay to detect SARS-CoV-2 seroconversion in humans F Amanat, D Stadlbauer, S Strohmeier, THO Nguyen, V Chromikova, ... Nature medicine 26 (7), 1033-1036, 2020 | 2082 | 2020 |
| Antibody responses in seropositive persons after a single dose of SARS-CoV-2 mRNA vaccine F Krammer, K Srivastava, H Alshammary, AA Amoako, MH Awawda, ... New England Journal of Medicine 384 (14), 1372-1374, 2021 | 853 | 2021 |
| Cytokine levels in the serum of healthy subjects. G Kleiner, A Marcuzzi, V Zanin, L Monasta, G Zauli Mediators of Inflammation 2013, 2013 | 482 | 2013 |
| Introductions and early spread of SARS-CoV-2 in the New York City area AS Gonzalez-Reiche, MM Hernandez, MJ Sullivan, B Ciferri, ... Science 369 (6501), 297-301, 2020 | 434 | 2020 |
| SARS-CoV-2 spike E484K mutation reduces antibody neutralisation S Jangra, C Ye, R Rathnasinghe, D Stadlbauer, H Alshammary, ... The Lancet Microbe 2 (7), e283-e284, 2021 | 431 | 2021 |
| SARS-CoV-2 mRNA vaccination induces functionally diverse antibodies to NTD, RBD, and S2 F Amanat, M Thapa, T Lei, SMS Ahmed, DC Adelsberg, JM Carreño, ... Cell 184 (15), 3936-3948. e10, 2021 | 276 | 2021 |
| Highly variable SARS-CoV-2 spike antibody responses to two doses of COVID-19 RNA vaccination in patients with multiple myeloma O Van Oekelen, CR Gleason, S Agte, K Srivastava, KF Beach, A Aleman, ... Cancer cell 39 (8), 1028-1030, 2021 | 215 | 2021 |
| Decreased coenzyme Q10 levels in multiple system atrophy cerebellum E Barca, G Kleiner, G Tang, M Ziosi, S Tadesse, E Masliah, ED Louis, ... Journal of Neuropathology & Experimental Neurology 75 (7), 663-672, 2016 | 84 | 2016 |
| Metabolic reprogramming by dual AKT/ERK inhibition through imipridones elicits unique vulnerabilities in glioblastoma CT Ishida, Y Zhang, E Bianchetti, C Shu, TTT Nguyen, G Kleiner, ... Clinical Cancer Research 24 (21), 5392-5406, 2018 | 80 | 2018 |
| Variable cellular responses to SARS-CoV-2 in fully vaccinated patients with multiple myeloma A Aleman, B Upadhyaya, K Tuballes, K Kappes, CR Gleason, K Beach, ... Cancer Cell 39 (11), 1442-1444, 2021 | 79 | 2021 |
| Coenzyme Q deficiency causes impairment of the sulfide oxidation pathway M Ziosi, I Di Meo, G Kleiner, XH Gao, E Barca, MJ Sanchez‐Quintero, ... EMBO molecular medicine 9 (1), 96-111, 2017 | 72 | 2017 |
| Mpox vaccine and infection-driven human immune signatures: an immunological analysis of an observational study H Cohn, N Bloom, GY Cai, JJ Clark, A Tarke, MC Bermúdez-González, ... The Lancet Infectious Diseases 23 (11), 1302-1312, 2023 | 71 | 2023 |
| Anti-amnesic and neuroprotective actions of the sigma-1 receptor agonist (-)-MR22 in rats with selective cholinergic lesion and amyloid infusion V Antonini, A Marrazzo, G Kleiner, M Coradazzi, S Ronsisvalle, ... Journal of Alzheimer’s disease 24 (3), 569-586, 2011 | 61 | 2011 |
| Mitochondrial dysregulation and impaired autophagy in iPSC-derived dopaminergic neurons of multiple system atrophy GM Compagnoni, G Kleiner, M Samarani, M Aureli, G Faustini, A Bellucci, ... Stem Cell Reports 11 (5), 1185-1198, 2018 | 59 | 2018 |
| The role of sulfide oxidation impairment in the pathogenesis of primary CoQ deficiency CM Quinzii, M Luna-Sanchez, M Ziosi, A Hidalgo-Gutierrez, G Kleiner, ... Frontiers in physiology 8, 525, 2017 | 51 | 2017 |
| Mevalonate kinase deficiency and neuroinflammation: balance between apoptosis and pyroptosis PM Tricarico, A Marcuzzi, E Piscianz, L Monasta, S Crovella, G Kleiner International journal of molecular sciences 14 (12), 23274-23288, 2013 | 51 | 2013 |
| Phenotypes of disease severity in a cohort of hospitalized COVID-19 patients: results from the IMPACC study A Ozonoff, J Schaenman, ND Jayavelu, CE Milliren, CS Calfee, CB Cairns, ... EBioMedicine 83, 2022 | 46 | 2022 |
| Inefficient thermogenic mitochondrial respiration due to futile proton leak in a mouse model of fragile X syndrome KK Griffiths, A Wang, L Wang, M Tracey, G Kleiner, CM Quinzii, L Sun, ... The FASEB Journal 34 (6), 7404-7426, 2020 | 46 | 2020 |
| MET inhibition elicits PGC1α-dependent metabolic reprogramming in glioblastoma Y Zhang, TTT Nguyen, E Shang, A Mela, N Humala, A Mahajan, J Zhao, ... Cancer research 80 (1), 30-43, 2020 | 46 | 2020 |
| Combined HDAC and bromodomain protein inhibition reprograms tumor cell metabolism and elicits synthetic lethality in glioblastoma Y Zhang, CT Ishida, W Ishida, SFL Lo, J Zhao, C Shu, E Bianchetti, ... Clinical Cancer Research 24 (16), 3941-3954, 2018 | 46 | 2018 |
Annalisa MarcuzziUniversità degli Studi di FerraraПідтверджена електронна адреса в burlo.trieste.it
